Intellia Therapeutics, Inc. (NTLA)
USD 5.98
(-9.8%)
USD 5.98
(-9.8%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -506.31 Million USD | -13.84% |
| 2022 | -450.59 Million USD | -66.02% |
| 2021 | -260.95 Million USD | -96.11% |
| 2020 | -130.27 Million USD | -35.52% |
| 2019 | -100.78 Million USD | -10.91% |
| 2018 | -86.4 Million USD | -30.64% |
| 2017 | -66.56 Million USD | -116.28% |
| 2016 | -31.05 Million USD | -145.85% |
| 2015 | -13.08 Million USD | -150.52% |
| 2014 | -9.53 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -111.49 Million USD | 18.87% |
| 2024 Q2 | -136.44 Million USD | -22.38% |
| 2023 FY | - USD | -13.84% |
| 2023 Q4 | -137.42 Million USD | -4.82% |
| 2023 Q2 | -132.33 Million USD | -18.31% |
| 2023 Q1 | -111.85 Million USD | -6.88% |
| 2023 Q3 | -131.1 Million USD | 0.93% |
| 2022 Q2 | -98.47 Million USD | 30.69% |
| 2022 Q4 | -104.66 Million USD | -9.28% |
| 2022 FY | - USD | -66.02% |
| 2022 Q1 | -142.07 Million USD | -76.67% |
| 2022 Q3 | -95.77 Million USD | 2.74% |
| 2021 Q1 | -44.83 Million USD | -5.74% |
| 2021 FY | - USD | -96.11% |
| 2021 Q4 | -80.41 Million USD | -14.54% |
| 2021 Q3 | -70.2 Million USD | -4.19% |
| 2021 Q2 | -67.38 Million USD | -50.29% |
| 2020 Q3 | -26.5 Million USD | 15.79% |
| 2020 Q2 | -31.46 Million USD | 0.12% |
| 2020 Q1 | -31.5 Million USD | -11.77% |
| 2020 Q4 | -42.39 Million USD | -60.0% |
| 2020 FY | - USD | -35.52% |
| 2019 Q4 | -28.18 Million USD | -17.72% |
| 2019 FY | - USD | -10.91% |
| 2019 Q1 | -22.51 Million USD | -8.5% |
| 2019 Q2 | -26.13 Million USD | -16.12% |
| 2019 Q3 | -23.94 Million USD | 8.39% |
| 2018 Q1 | -21.41 Million USD | 13.34% |
| 2018 FY | - USD | -30.64% |
| 2018 Q4 | -20.74 Million USD | 9.59% |
| 2018 Q3 | -22.94 Million USD | -1.89% |
| 2018 Q2 | -22.52 Million USD | -5.15% |
| 2017 Q3 | -15.08 Million USD | 1.44% |
| 2017 FY | - USD | -116.28% |
| 2017 Q4 | -24.71 Million USD | -63.84% |
| 2017 Q1 | -12.28 Million USD | -13.55% |
| 2017 Q2 | -15.3 Million USD | -24.56% |
| 2016 Q1 | -6.5 Million USD | -21.42% |
| 2016 Q2 | -6.69 Million USD | -2.95% |
| 2016 FY | - USD | -145.85% |
| 2016 Q4 | -10.82 Million USD | -45.61% |
| 2016 Q3 | -7.43 Million USD | -10.94% |
| 2015 Q3 | -3.2 Million USD | 4.47% |
| 2015 FY | - USD | -150.52% |
| 2015 Q4 | -5.35 Million USD | -67.21% |
| 2015 Q1 | -1.16 Million USD | 72.25% |
| 2015 Q2 | -3.35 Million USD | -188.73% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | -4.18 Million USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -163.489% |
| Alkermes plc | 495.04 Million USD | 202.276% |
| Agenus Inc. | -145.92 Million USD | -246.972% |
| Aptorum Group Limited | -9.59 Million USD | -5174.666% |
| Ardelyx, Inc. | -55.35 Million USD | -814.685% |
| Dyadic International, Inc. | -8.22 Million USD | -6052.261% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -173891.409% |
| Lantern Pharma Inc. | -15.78 Million USD | -3107.227% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2442.713% |
| Novavax, Inc. | -487.39 Million USD | -3.883% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -612.879% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -545.045% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2717.016% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -4979.404% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -782.452% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -33.252% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1999.855% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 95811.72% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -222.094% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -576.757% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2411.608% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -2033.2% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -2095.832% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -314.662% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -96.062% |
| AlloVir, Inc. | -190.14 Million USD | -166.277% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -188.216% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1630.518% |
| Bicycle Therapeutics plc | -183.4 Million USD | -176.071% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -206.077% |
| ChromaDex Corporation | -3.89 Million USD | -12902.44% |
| Chimerix, Inc. | -92.97 Million USD | -444.577% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -1039.407% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -349.922% |
| CRISPR Therapeutics AG | -202.7 Million USD | -149.784% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1480.16% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -193.978% |
| Fortress Biotech, Inc. | -133.64 Million USD | -278.856% |
| Fortress Biotech, Inc. | -133.64 Million USD | -278.856% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -554.636% |
| ImmuCell Corporation | -2.5 Million USD | -20119.626% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -288.216% |
| Immix Biopharma, Inc. | -16.13 Million USD | -3037.867% |
| Incyte Corporation | 919.42 Million USD | 155.069% |
| Innoviva, Inc. | 248.96 Million USD | 303.372% |
| IO Biotech, Inc. | -91.22 Million USD | -455.0% |
| Jaguar Health, Inc. | -33.13 Million USD | -1428.221% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -232.715% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 597.719% |
| ContextLogic Inc. | -324 Million USD | -56.27% |
| MiMedx Group, Inc. | 40.51 Million USD | 1349.636% |
| MEI Pharma, Inc. | 26.38 Million USD | 2019.314% |
| NextCure, Inc. | -59.03 Million USD | -757.594% |
| Onconetix, Inc. | -36.7 Million USD | -1279.352% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 22753.915% |
| Opthea Limited | -200.01 Million USD | -153.134% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -18300.882% |
| Vaxcyte, Inc. | -464.88 Million USD | -8.912% |
| PDS Biotechnology Corporation | -40.08 Million USD | -1163.104% |
| Precigen, Inc. | -89.22 Million USD | -467.452% |
| Pharming Group N.V. | 9.87 Million USD | 5226.202% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -218.339% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -2124.387% |
| PureTech Health plc | -11.62 Million USD | -4254.649% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2881.656% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -116.84% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1999.855% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -479.129% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1648.144% |
| Acelyrin, Inc. | -381.52 Million USD | -32.708% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -3929425.204% |
| Summit Therapeutics Inc. | 1 Million USD | 50680.919% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1416.549% |
| Senti Biosciences, Inc. | -61.33 Million USD | -725.478% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -350.843% |
| Elevation Oncology, Inc. | -41.46 Million USD | -1121.007% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1538.348% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -8177.793% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -157630.53% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1460.149% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -5930.431% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -761.226% |
| Seer, Inc. | -97.88 Million USD | -417.255% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -714.051% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -674.596% |
| ESSA Pharma Inc. | -26.45 Million USD | -1813.85% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1194.195% |
| GT Biopharma, Inc. | 5.97 Million USD | 8568.222% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -144.96% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -7272.088% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 683.232% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -792.122% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -888.53% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -5021.067% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 6.225% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -7254.954% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -980.438% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -113.976% |
| Aptose Biosciences Inc. | -52.26 Million USD | -868.69% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -369.927% |
| Soligenix, Inc. | -7.85 Million USD | -6347.532% |
| Century Therapeutics, Inc. | -121.2 Million USD | -317.724% |
| Kura Oncology, Inc. | -164.95 Million USD | -206.941% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -532.119% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -4919.978% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -52765.655% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -11650.174% |
| Autolus Therapeutics plc | -156.77 Million USD | -222.967% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -498.078% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -633.779% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2439.957% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -167.505% |
| GRI Bio, Inc. | -10.89 Million USD | -4545.944% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -11112.289% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -313.298% |
| IGM Biosciences, Inc. | -253.35 Million USD | -99.842% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -387.817% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1227.753% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3202.577% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -3116.078% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -790.694% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -372.737% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -90.346% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -161.069% |
| Verastem, Inc. | -83.16 Million USD | -508.8% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -901.177% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -219.991% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -343.789% |
| Histogen Inc. | -10.5 Million USD | -4720.67% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -3445.696% |
| Surrozen, Inc. | -41.13 Million USD | -1130.981% |
| Organovo Holdings, Inc. | -14.8 Million USD | -3319.661% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 15787907.92% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -762.353% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -887.084% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -2250.689% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -5972.376% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -204.887% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -927.874% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1995.154% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -3263.093% |
| Apollomics, Inc. | -171.74 Million USD | -194.803% |
| Amarin Corporation plc | -50.9 Million USD | -894.695% |
| Mesoblast Limited | -61.33 Million USD | -725.545% |
| Turnstone Biologics Corp. | -56.23 Million USD | -800.372% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -253.569% |
| Synaptogenix, Inc. | -8.3 Million USD | -5994.668% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -3200.834% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -703.075% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10467.016% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 118111.416% |
| Exelixis, Inc. | 196.6 Million USD | 357.533% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1223.284% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -258.05% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | -2.242% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4192.386% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 204906.728% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1615.973% |
| Gritstone bio, Inc. | -126.86 Million USD | -299.104% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -679.126% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -12558.046% |
| Avid Bioservices, Inc. | -11.48 Million USD | -4310.025% |
| Insmed Incorporated | -654.73 Million USD | 22.669% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -22405.7% |
| MediWound Ltd. | -4.89 Million USD | -10247.742% |
| OmniAb, Inc. | -49.73 Million USD | -918.107% |
| Alector, Inc. | -142.89 Million USD | -254.334% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -492.639% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -870.919% |
| Zai Lab Limited | -366.57 Million USD | -38.121% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -74.209% |
| Aura Biosciences, Inc. | -83.69 Million USD | -504.945% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -124.78% |
| Immunic, Inc. | -99.11 Million USD | -410.851% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -284.533% |
| Veracyte, Inc. | -49.4 Million USD | -924.742% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -7067.61% |
| FibroGen, Inc. | -261.4 Million USD | -93.69% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4444.61% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7131.699% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2605.127% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 134.932% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1891.641% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1369.278% |
| TG Therapeutics, Inc. | 26.1 Million USD | 2039.904% |
| Galecto, Inc. | -37.51 Million USD | -1249.49% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1223.18% |
| Fortrea Holdings Inc. | 167.3 Million USD | 402.639% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -277.059% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1688.404% |
| XBiotech Inc. | -35.76 Million USD | -1315.632% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -679.126% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -675.962% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -384.721% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1872.246% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -1138.934% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 1.963% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -803.795% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -903211.27% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -335.222% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -2183.83% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -115.395% |
| NexImmune, Inc. | -28.16 Million USD | -1697.514% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -9063.164% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -4193.617% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 110.879% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1893.994% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4222.621% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -302.329% |
| Ainos, Inc. | -8.77 Million USD | -5671.222% |
| Pluri Inc. | -20.22 Million USD | -2403.412% |
| Prothena Corporation plc | -190.1 Million USD | -166.33% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -294.948% |
| Celularity Inc. | -183.94 Million USD | -175.252% |
| Rallybio Corporation | -72.37 Million USD | -599.591% |
| Cue Biopharma, Inc. | -46.05 Million USD | -999.442% |
| MeiraGTx Holdings plc | -57.05 Million USD | -787.462% |
| Omeros Corporation | -163.61 Million USD | -209.465% |
| Humacyte, Inc. | -96.45 Million USD | -424.907% |
| Immunocore Holdings plc | -59.64 Million USD | -748.824% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2513.643% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1978.042% |
| Blueprint Medicines Corporation | -474.61 Million USD | -6.68% |
| CalciMedica, Inc. | -34.18 Million USD | -1380.93% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -591.366% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -303.448% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -200.571% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -100.608% |
| Pulmatrix, Inc. | -12.64 Million USD | -3903.756% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1435.87% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -472.321% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -400.237% |
| Cytokinetics, Incorporated | -456.68 Million USD | -10.868% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1417.14% |
| Nutriband Inc. | -5.12 Million USD | -9785.534% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -1070.075% |
| Vor Biopharma Inc. | -114.37 Million USD | -342.695% |
| Roivant Sciences Ltd. | -996.51 Million USD | 49.191% |
| Evogene Ltd. | -23.2 Million USD | -2082.016% |
| ProKidney Corp. | -147.66 Million USD | -242.872% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -684.559% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -330502.877% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 10.461% |
| CorMedix Inc. | -48.88 Million USD | -935.684% |
| BioLineRx Ltd. | -57.06 Million USD | -787.322% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -353.046% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -250550.99% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1294.385% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -536.738% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -522.674% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -83.778% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1547.088% |
| MediciNova, Inc. | -9.87 Million USD | -5024.661% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -302.026% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -32988.137% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1798.532% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -125.038% |
| Biomea Fusion, Inc. | -124.62 Million USD | -306.287% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -53.271% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1843.18% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -166.007% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -120.192% |
| Absci Corporation | -95.45 Million USD | -430.412% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1586.311% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -372.67% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -116.86% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -2115.336% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -143.613% |
| Allakos Inc. | -189.91 Million USD | -166.601% |
| Imunon, Inc. | -19.87 Million USD | -2447.077% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -366.684% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 567.408% |
| BioAtla, Inc. | -122.24 Million USD | -314.194% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4192.386% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -3112.455% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -68.607% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -1121.596% |
| XOMA Corporation | -39.36 Million USD | -1186.304% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -410.12% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -330.357% |
| aTyr Pharma, Inc. | -52.17 Million USD | -870.361% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -504.086% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -240.652% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -115.853% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3608.452% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -6195.649% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2913.421% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 268408.904% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 212.03% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -7825.258% |
| UroGen Pharma Ltd. | -63.83 Million USD | -693.212% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -645.513% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -6871.144% |
| Orgenesis Inc. | -60.71 Million USD | -733.88% |
| Entera Bio Ltd. | -8.8 Million USD | -5650.965% |
| GH Research PLC | -41.15 Million USD | -1130.323% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1884.071% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -515.708% |
| Xencor, Inc. | -125.87 Million USD | -302.24% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -35392.396% |
| Replimune Group, Inc. | -230.19 Million USD | -119.948% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2411.78% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -4527.262% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -7825.258% |
| Portage Biotech Inc. | -18.19 Million USD | -2682.103% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -32988.137% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -384.123% |
| OncoCyte Corporation | -23.12 Million USD | -2089.66% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4380.52% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4319.325% |
| Purple Biotech Ltd. | -22.22 Million USD | -2178.133% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -7798.83% |
| scPharmaceuticals Inc. | -46.06 Million USD | -999.227% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2742.92% |
| HilleVax, Inc. | -132.46 Million USD | -282.223% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -4661.732% |
| Tharimmune, Inc. | -9.3 Million USD | -5342.732% |
| Genprex, Inc. | -31.06 Million USD | -1530.089% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -169.997% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1514.834% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -66171.597% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 335621.259% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3215441.599% |
| Savara Inc. | -59.13 Million USD | -756.231% |
| Curis, Inc. | -45.13 Million USD | -1021.68% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1549.153% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -3232.961% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -6966.504% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1793.899% |
| BeiGene, Ltd. | -1.12 Billion USD | 54.979% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -3005.998% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -17.589% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -460.455% |
| Erasca, Inc. | -121.31 Million USD | -317.373% |
| bluebird bio, Inc. | -167.16 Million USD | -202.891% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -11154.556% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 263.178% |
| DBV Technologies S.A. | -85.98 Million USD | -488.862% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -11154.556% |
| Moderna, Inc. | -3.28 Billion USD | 84.578% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1088.282% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -8864.501% |
| Molecular Templates, Inc. | 1.43 Million USD | 35506.643% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -745.945% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -55.194% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -269.333% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -968.942% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -264.166% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -145.951% |
| MacroGenics, Inc. | 2.01 Million USD | 25202.38% |
| RenovoRx, Inc. | -11.39 Million USD | -4345.259% |
| Adicet Bio, Inc. | -136.53 Million USD | -270.832% |
| Prime Medicine, Inc. | -193.75 Million USD | -161.312% |
| Aditxt, Inc. | -25.45 Million USD | -1888.828% |
| Adagene Inc. | -14.95 Million USD | -3286.545% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6826.241% |
| Quantum-Si incorporated | -91.8 Million USD | -451.517% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 171.071% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 500.391% |
| SciSparc Ltd. | -5.28 Million USD | -9485.668% |
| Vericel Corporation | 2.86 Million USD | 17778.596% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -531698.798% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -2234.171% |
| Generation Bio Co. | -133.3 Million USD | -279.831% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -509.798% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -488.581% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -122.621% |
| Invivyd, Inc. | -196.61 Million USD | -157.516% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -35.323% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -5359.041% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1964.606% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4822.849% |
| 2seventy bio, Inc. | -206.41 Million USD | -145.286% |
| ADMA Biologics, Inc. | 5.12 Million USD | 9988.965% |
| Clene Inc. | -43.24 Million USD | -1070.914% |
| Capricor Therapeutics, Inc. | -23 Million USD | -2100.511% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -944.444% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1798.532% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -69.016% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1278.502% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 2247.86% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 10411.379% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1458.756% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -219.635% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 26.01% |
| Evaxion Biotech A/S | -21.4 Million USD | -2265.626% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -662.35% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -132.608% |
| Trevena, Inc. | -35.28 Million USD | -1334.808% |
| Surrozen, Inc. | -41.13 Million USD | -1130.981% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -536.138% |
| Cingulate Inc. | -22.95 Million USD | -2105.97% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -6686.155% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1258.032% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -6054.78% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -395.096% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -646.48% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -767.394% |
| Clearmind Medicine Inc. | -8.71 Million USD | -5712.589% |
| Kronos Bio, Inc. | -121.83 Million USD | -315.591% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -581.062% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -20638.597% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -402.162% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1400.413% |
| ImmunityBio, Inc. | -436.18 Million USD | -16.079% |
| Korro Bio, Inc. | -80.9 Million USD | -525.822% |
| Kineta, Inc. | -15.71 Million USD | -3122.063% |
| BioVie Inc. | -31.95 Million USD | -1484.7% |
| Codexis, Inc. | -49.28 Million USD | -927.362% |
| Celularity Inc. | -183.94 Million USD | -175.252% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -128.574% |
| Celcuity Inc. | -58.3 Million USD | -768.317% |
| Virax Biolabs Group Limited | -6.6 Million USD | -7560.826% |
| Cibus, Inc. | -314.58 Million USD | -60.947% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1400.949% |
| IN8bio, Inc. | -28.5 Million USD | -1676.295% |
| Kodiak Sciences Inc. | -259.02 Million USD | -95.471% |
| Annexon, Inc. | -141.57 Million USD | -257.63% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -349.662% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -688.702% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1711.179% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -120.127% |
| Eyenovia, Inc. | -24.1 Million USD | -2000.366% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1230.571% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -156170.062% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -586.027% |
| Arcellx, Inc. | -64.14 Million USD | -689.329% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -1024.795% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -310.051% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1539.515% |
| Moolec Science SA | -52.07 Million USD | -872.27% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -881.117% |
| Geron Corporation | -174.78 Million USD | -189.684% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -1152.728% |
| Royalty Pharma plc | 1.88 Billion USD | 126.828% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -323.365% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5330.086% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -2341.16% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -204.862% |
| Humacyte, Inc. | -96.45 Million USD | -424.907% |
| Structure Therapeutics Inc. | -102.45 Million USD | -394.164% |
| 89bio, Inc. | -134.46 Million USD | -276.546% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -541.921% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 12595.434% |
| Genelux Corporation | -24.16 Million USD | -1995.241% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1397.973% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -209.741% |
| Notable Labs, Ltd. | -14.4 Million USD | -3416.076% |
| Liquidia Corporation | -70.05 Million USD | -622.781% |
| Mustang Bio, Inc. | -48.06 Million USD | -953.44% |
| Immunovant, Inc. | -269.97 Million USD | -87.539% |
| Quantum-Si incorporated | -91.8 Million USD | -451.517% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -613.26% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2522.307% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -396.329% |
| Acasti Pharma Inc. | -11.3 Million USD | -4380.267% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -2175.242% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3202.577% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -140.515% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -11756.542% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3088.382% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1659.504% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1267.31% |
| PepGen Inc. | -83.58 Million USD | -505.77% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1616.089% |
| United Therapeutics Corporation | 1.38 Billion USD | 136.51% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2111.272% |
| Solid Biosciences Inc. | -93.43 Million USD | -441.896% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -10510.709% |
| Immuneering Corporation | -58.06 Million USD | -772.043% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 15787907.92% |
| Silo Pharma, Inc. | -3.62 Million USD | -13862.634% |
| Belite Bio, Inc | -31.52 Million USD | -1505.871% |
| XOMA Corporation | -39.36 Million USD | -1186.304% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -650.686% |
| Bionomics Limited | -9.83 Million USD | -5047.049% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -502.864% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1363.084% |
| uniQure N.V. | -253.1 Million USD | -100.045% |
| Cassava Sciences, Inc. | -95.68 Million USD | -429.137% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6826.241% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -290.965% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1458.996% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -6189.258% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1694.234% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -156170.062% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4444.61% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -3084.171% |
| Altimmune, Inc. | -87.93 Million USD | -475.783% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -449.87% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1363.084% |
| Compugen Ltd. | -12.51 Million USD | -3945.342% |
| Peak Bio, Inc. | -1356.23 USD | -37332432.093% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -941.843% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2151.289% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -108.959% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1673.867% |
| Zura Bio Limited | -60.56 Million USD | -736.014% |
| PolyPid Ltd. | -20.26 Million USD | -2398.717% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -3142.907% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1673.867% |
| Instil Bio, Inc. | -146.12 Million USD | -246.502% |
| argenx SE | -216.02 Million USD | -134.38% |
| Immunome, Inc. | -28.27 Million USD | -1690.934% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -944.53% |
| Verona Pharma plc | -52.46 Million USD | -865.005% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -434.245% |
| Shattuck Labs, Inc. | -87.61 Million USD | -477.886% |
| CervoMed Inc. | -2.17 Million USD | -23212.356% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -314.184% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -3888.931% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -951.013% |
| Moolec Science SA | -52.07 Million USD | -872.27% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2853.999% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -288.305% |
| AnaptysBio, Inc. | -143.16 Million USD | -253.661% |
| Design Therapeutics, Inc. | -66.32 Million USD | -663.385% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -525.181% |
| NeurAxis, Inc. | -6.66 Million USD | -7497.2% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1241.232% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1284.509% |
| Achilles Therapeutics plc | -70.44 Million USD | -618.769% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -434.245% |
| 180 Life Sciences Corp. | -22.13 Million USD | -2187.496% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 8785.77% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -20638.597% |
| Nutriband Inc. | -5.12 Million USD | -9785.534% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -361.343% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -813.398% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -901.612% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -675.641% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -835.715% |
| Palisade Bio, Inc. | -12.28 Million USD | -4022.751% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -1015.821% |
| Beam Therapeutics Inc. | -156.47 Million USD | -223.58% |
| Neurogene Inc. | -52.28 Million USD | -868.357% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -270.954% |
| AEON Biopharma, Inc. | -48.36 Million USD | -946.949% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -444.319% |
| Sesen Bio, Inc. | -50.84 Million USD | -895.899% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -517.97% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -3999.709% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -18.455% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -381.302% |
| Athira Pharma, Inc. | -116.7 Million USD | -333.849% |
| Vaccinex, Inc. | -19.74 Million USD | -2463.88% |
| HCW Biologics Inc. | -23.57 Million USD | -2047.581% |
| XOMA Corporation | -39.36 Million USD | -1186.304% |
| Nektar Therapeutics | -243.1 Million USD | -108.268% |
| Arvinas, Inc. | -394.8 Million USD | -28.246% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 268408.904% |
| Merus N.V. | -149.2 Million USD | -239.337% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -441.571% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1519.69% |
| Rezolute, Inc. | -68.42 Million USD | -639.978% |
| Clene Inc. | -43.24 Million USD | -1070.914% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3183.029% |
| BeyondSpring Inc. | -21.54 Million USD | -2250.58% |
| Synlogic, Inc. | -55.16 Million USD | -817.886% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -4090.309% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -4657.705% |
| Peak Bio, Inc. | -1356.23 USD | -37332432.093% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1459.572% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2927.943% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -327.548% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -48.329% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -10891.479% |
| MannKind Corporation | 15.12 Million USD | 3446.652% |
| Ikena Oncology, Inc. | -74.39 Million USD | -580.558% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -3920.607% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2590.85% |
| Gossamer Bio, Inc. | -172.15 Million USD | -194.109% |
| CohBar, Inc. | -12.06 Million USD | -4096.296% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1884.848% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1586.311% |
| Legend Biotech Corporation | -477.87 Million USD | -5.952% |
| Mural Oncology plc | -192.72 Million USD | -162.721% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -343.926% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3035.996% |
| Disc Medicine, Inc. | -91.02 Million USD | -456.237% |
| Champions Oncology, Inc. | -5.05 Million USD | -9918.104% |
| REGENXBIO Inc. | -239.46 Million USD | -111.437% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4623.887% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -808.091% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1206.004% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -348.837% |
| Vaxart, Inc. | -74.72 Million USD | -577.589% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1338.056% |
| Cellectis S.A. | -98.09 Million USD | -416.148% |
| Longeveron Inc. | -20.06 Million USD | -2424.003% |
| Repare Therapeutics Inc. | -114.27 Million USD | -343.075% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -15.282% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -576.783% |
| Revolution Medicines, Inc. | -430.58 Million USD | -17.589% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -7950.803% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1544.467% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -578.797% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 10426.637% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -4517.556% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 110.994% |
| Denali Therapeutics Inc. | -179.97 Million USD | -181.328% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -531698.798% |
| Veru Inc. | -89.97 Million USD | -462.725% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1783.753% |
| Cingulate Inc. | -22.95 Million USD | -2105.97% |
| Passage Bio, Inc. | -98.34 Million USD | -414.856% |
| Context Therapeutics Inc. | -25.06 Million USD | -1920.365% |
| Exicure, Inc. | -15.53 Million USD | -3158.35% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -145.708% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1269.307% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -8391.519% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -200.548% |
| Nuvalent, Inc. | -149.49 Million USD | -238.69% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -6125.887% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -489.465% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1577.762% |
| OmniAb, Inc. | -49.73 Million USD | -918.107% |
| Anew Medical, Inc. | -1.3 Million USD | -38822.158% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -3995.074% |
| Lipocine Inc. | -16.32 Million USD | -3001.914% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -659.435% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -581.419% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1227.753% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1197.778% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -2182.446% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 7.11% |
| Ocugen, Inc. | -64.82 Million USD | -681.025% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -446.954% |
| Q32 Bio Inc. | -86.5 Million USD | -485.322% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2891.168% |
| Alumis Inc. Common Stock | -156.89 Million USD | -222.72% |
| Equillium, Inc. | -12.13 Million USD | -4071.321% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -765.91% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6306.335% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2584.458% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -984.372% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -376.106% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2730.696% |
| Dominari Holdings Inc. | -22.44 Million USD | -2156.306% |
| Edesa Biotech, Inc. | -8.19 Million USD | -6082.005% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1892.425% |
| Bio-Techne Corporation | 326.66 Million USD | 254.996% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -31.557% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 333.984% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -286.182% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1252.662% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -235.084% |
| Nkarta, Inc. | -120.48 Million USD | -320.245% |
| BioCardia, Inc. | -11.56 Million USD | -4279.888% |
| Iterum Therapeutics plc | -34.58 Million USD | -1364.184% |